WASHINGTON, Jan 29 (Reuters) - U.S. President Donald Trump said on Thursday that the head of Eli Lilly has told him the ...

Economic developer Don Erwin explains what Birmingham can learn from Alabama's 1993 Mercedes-Benz win, when enthusiasm and regional partnership overcame the state's challenges to land what became the ...

Patients know about nausea and vomiting. Now, lawsuits are raising concerns about vision loss.

By Christy Santhosh Jan 29 (Reuters) - Drugmaker Eli Lilly is partnering with Repertoire Immune Medicines in a deal worth up ...

Artificial intelligence (AI) is impacting, and will eventually impact, nearly every sector and industry, including ...

The drugmaker's full-year results didn't seem to move the needle for investors who are instead focused on future growth ...

Some patients have pointed to severe undisclosed side effects, including blindness, loss of brain function and organ damage.

Wegovy, Ozempic, and Zepbound makers will show up in and around the Big Game.

Last year, there was a 15% annual increase in the operations and surgeons want more research.

Eli Lilly signs major deals with Repertoire Immune and Seamless Therapeutics, committing billions to autoimmune disease ...

U.S. drugmaker Eli Lilly and Company signed an agreement worth up to $1.12 billion with Seamless Therapeutics, the ...

Repertoire Immune Medicines partners with Eli Lilly to develop tolerizing therapies for autoimmune diseases, receiving $85 ...